-transparent.png){kind=logo}
High-resolution capillary gas chromatography-mass spectrometry with selective ion monitoring and using deuterated 3-tert-butyl-4-hydroxyanisole (BHA) as an internal standard was used to measure BHA in the plasma and urine of human volunteers after oral administration of 30 or 5 mg of the compound in olive oil. Pharmacokinetic studies showed similar plasma-concentration profiles in subjects treated with either level of BHA. About 20% of the administered dose was excreted as BHA glucuronide in the urine within the first 24 hr.
Related Publications
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
May 1997,
Cancer letters,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
March 1977,
Journal of chromatography,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
May 1992,
FEBS letters,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
August 1985,
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
June 1990,
Mutation research,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
November 1985,
Biochemical pharmacology,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
November 1990,
Carcinogenesis,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
June 1987,
Research communications in chemical pathology and pharmacology,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
April 1985,
Cancer research,
M G Castelli, and
E Benfenati, and
R Pastorelli, and
M Salmona, and
R Fanelli
December 1984,
Research communications in chemical pathology and pharmacology,
